The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Watson Pharmaceuticals
Approval Status: Approved January 1997
Treatment for: mild-to moderate hypertension
General Information
Microzide has been approved for the treatment of mild-to moderate hypertension.